Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients

American Journal of Public Health
Jennifer C SpencerStacie B Dusetzina

Abstract

To assess predictors of timely human papillomavirus (HPV) vaccine follow-through among privately insured individuals initiating the 3-dose series. Using MarketScan Commercial claims data, we identified 1 332 217 privately insured US individuals aged 9 to 26 years who initiated the bivalent or quadrivalent HPV vaccine series from 2006 to 2014, with follow-up data extending through 2015. The study outcome was receipt of third HPV dose within 12 months of the first, compared by year of initiation. Control variables were age, region, insurance plan type, provider type, and seasonal influenza vaccination. Timely HPV vaccine follow-through fell over time. The trend was especially pronounced for females (from 67% in 2006 to 38% in 2014), but was also present for males (from 36% in 2011 to 33% in 2014). Similar patterns were present when we controlled for patient and provider characteristics or used alternative definitions of follow-through. Other positive predictors of timely follow-through included receipt of flu vaccine in the prior year and receipt of first HPV vaccine dose from an obstetrician/gynecologist. HPV vaccine follow-through is low and has declined over time.

References

Jun 22, 2011·Obstetrics and Gynecology·Betty ChouCornelia L Trimble
Oct 4, 2011·American Journal of Preventive Medicine·Linda M NiccolaiJames L Hadler
Jul 3, 2013·Public Health Nursing·Katharine J HeadLaurel A Mills
Nov 28, 2013·Infectious Disease Clinics of North America·Eileen F Dunne, Ina U Park
Mar 19, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Paul L ReiterJennifer S Smith
Apr 8, 2015·Clinical Pediatrics·Mahbubur RahmanAbbey B Berenson
May 20, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S Pils, E A Joura
Aug 26, 2016·Qualitative Health Research·Katharine A Rendle, Emily A Leskinen
Aug 26, 2016·MMWR. Morbidity and Mortality Weekly Report·Sarah Reagan-SteinerJames A Singleton
Feb 28, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·E MeitesL E Markowitz
Aug 25, 2017·MMWR. Morbidity and Mortality Weekly Report·Tanja Y WalkerShannon Stokley

❮ Previous
Next ❯

Citations

Oct 1, 2018·Drugs·Samara PerezZeev Rosberger
Aug 6, 2020·Frontiers in Immunology·Xu ZhouYang Lin
Dec 17, 2020·Human Vaccines & Immunotherapeutics·Lane McLendonCasey L Daniel
Feb 8, 2021·BMC Public Health·Summer Sherburne HawkinsChristopher F Baum
Jul 15, 2021·American Journal of Preventive Medicine·Lisa N MansfieldRosa M Gonzalez-Guarda
Jan 24, 2019·Pediatrics·Parth D ShahNoel T Brewer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.